Teva Targets Amgen Over Kidney Drug
Teva Pharmaceutical Industries Ltd. has fired off a suit accusing Amgen Inc. of infringing its patent by making and selling Sensipar, a drug to treat kidney disease....To view the full article, register now.
Already a subscriber? Click here to view full article